Sunshine Biopharma
SBFM
10 hedge funds and large institutions have $346K invested in Sunshine Biopharma in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more funds holding
Funds holding: 8 → 10 (+2)
0% less ownership
Funds ownership: 0% → 0% (-0%)
54% less capital invested
Capital invested by funds: $746K → $346K (-$400K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$670K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$55.8K |
| 3 |
Jane Street
New York
|
+$11.8K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.81K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$578K |
| 2 |
VF
Virtu Financial
New York
|
-$6K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $279K | +$670K | +228 | +7,600% |
|
|
2
Citadel Advisors
Miami,
Florida
| $33.3K | +$55.8K | +19 | +211% |
|
|
BCM
3
Bridgeway Capital Management
Houston,
Texas
| $17.3K | – | – | – |
|
|
4
Jane Street
New York
| $5.3K | +$11.8K | +4 | New |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$8.81K | +3 | New |
|
|
XT
6
XTX Topco
George Town,
Cayman Islands
| $3.25K | +$5.88K | +2 | +200% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $1.22K | – | – | – |
|
8
Two Sigma Investments
New York
| $1.16K | +$2.94K | +1 | New |
|
|
HF
9
HRT Financial
New York
| $1K | +$2.94K | +1 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $600 | – | – | – |
|
|
MSG
11
Main Street Group
Glen Allen,
Virginia
| $24 | – | – | – |
|
|
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $5 | – | – | – |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $4 | – | – | – |
|
|
AC
14
Armistice Capital
New York
| – | -$578K | -107 | Closed |
|
|
VF
15
Virtu Financial
New York
| – | -$6K | -1 | Closed |
|
|
16
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$1.63K | – | – |
|
SBFM Hedge Fund Activity: Q1 2024 in Review
10 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q1 2024, worth a combined $346K — down 54% from $746K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SBFM positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $670K. The largest seller was Armistice Capital, exiting entirely with an estimated $578K sold.
- 10 institutional investors held Sunshine Biopharma (SBFM) as of Q1 2024, up from 8 in Q4 2023.
- Funds reported $346K of Sunshine Biopharma stock for Q1 2024, down 54% quarter-over-quarter.
- 4 funds opened new Sunshine Biopharma positions in Q1 2024 and 2 closed out, a net change of +2 holders.
- The largest Sunshine Biopharma buyer in Q1 2024 was Renaissance Technologies, an estimated $670K added.
- The largest Sunshine Biopharma seller in Q1 2024 was Armistice Capital, an estimated $578K sold.
Based on aggregated 13F filings for Q1 2024.